NCT04901806 2024-03-28Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid TumorsPyramid BiosciencesPhase 1 Terminated29 enrolled
NCT02982941 2022-02-08Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid TumorsMacroGenicsPhase 1 Completed25 enrolled